Pharmaceutical Advisory Committee

( Last Updated : January 23, 2020)

The Pharmaceutical Advisory Committee comprises representatives from the federal, provincial, and territorial publicly funded drug plans and other related health organizations. The Pharmaceutical Advisory Committee provides strategic advice on drug policy issues, including cancer-specific issues and drug topics, to CADTH and its Board. Committee members also facilitate the effective jurisdictional sharing of drug policy information.

Terms of Reference

Government of Manitoba Patricia Caetano
Saskatchewan Ministry of Health Nick Doulias
British Columbia Ministry of Health Tijana Fazlagic
British Columbia Cancer Agency Helen Anderson
Alberta Health Andrea Nagle
Ontario Ministry of Health Angie Wong
Cancer Care Ontario Scott Gavura
Nova Scotia Department of Health and Wellness Kathleen Coleman
New Brunswick Ministry of Health Kevin Pothier
Prince Edward Island Department of Health and Wellness Marsha Cusack
Newfoundland and Labrador Department of Health and Community Services Pam Barnes
Nova Scotia Cancer Care Program Joanne Houlihan
Government of Yukon Territory Marie-Claire Savoie
Government of Nunavut Donna Mulvey
Government of North West Territories Luke Spooner
NIHB Susan Pierce
Federal Drug Plans Harold Boudreau
Health Canada Lawrence Cheung
Hospital/Health Authority Jeremy Slobodan
Forces Michelle Sullivan
CAPCA Gunita Mitera
INESSS Sylvie Bouchard
pCPA Dominic Tan
PMPRB Tanya Potashnik